Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.

Xie, Lin

Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. [electronic resource] - International immunopharmacology May 2009 - 575-81 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1878-1705

10.1016/j.intimp.2009.01.025 doi


Animals
Cell Proliferation--drug effects
Curcuma
Curcumin--therapeutic use
Disease Progression
Dose-Response Relationship, Drug
Down-Regulation
Encephalomyelitis, Autoimmune, Experimental--drug therapy
Female
Freund's Adjuvant
Guinea Pigs
Humans
Immunization
Interleukin-17--genetics
Interleukin-6--genetics
Interleukins--genetics
Jurkat Cells
Multiple Sclerosis--immunology
Myelin Basic Protein--administration & dosage
Nuclear Receptor Subfamily 1, Group F, Member 3--genetics
Peptides--administration & dosage
Phosphorylation
Phytotherapy
Rats
Rats, Inbred Lew
Rhizome
STAT3 Transcription Factor--genetics
Spinal Cord--pathology
T-Lymphocytes, Helper-Inducer--drug effects
Transforming Growth Factor beta--genetics
Interleukin-21